Press

April 21^st 2021

A non-prescription intranasal application of APTT3X™ formulation will DECREASE the risk of contracting COVID-19 by 150% ...

September 4^th 2020

September 2^nd 2020

Independent Laboratory Testing Demonstrates APT™T3X Formulation Neutralizes COVID-19 (SARS-CoV-2 virus)

A Powerful Preventative in the Fight Against Covid-19. APT™T3X Formulation used as an Intra-nasal Application Provides an Additional Layer of Protection by Decreasing theViral Load of Exposure...

August 29^th 2020

TESTING THE VIRUCIDAL ACTIVITY OF APT™ T3X AGAINST SARS-COV2

A report prepared by Virology Research Services Ltd for Patient Focused Tele-Health, LLC...

August 24^th 2020

Scientists at Johns Hopkins Medicine, experimenting with a small number of human cell samples, report that the “hook” of cells used by SARS-CoV-2 to latch onto and infect cells is up to 700 times more prevalent in the olfactory...

August 19^th 2020

Another Reason We Need An Additional Layer of Protection With APT T3X!

August 14^th 2020

Indiana/Texas-Based Health Company Announces Successful Test of a Formulation that Blocks COVID (Coronavirus) from Nasal Passages

Advanced Penetration Technology, LLC, (APT) a Texas-and Indiana-based company (www.aptdeliverysystem.com) that specializes in innovative solutions for patient care utilizing non-prescription (OTC) products, today released results of an...

August 14^th 2020

A healthcare company based in Texas and Indiana has released results of an independent lab test of a topical medical formulation it says mitigates the coronavirus from entering the body through the nasal passages...

May 7^th 2020

We are currently in the midst of one of the world’s biggest challenges and threats, mitigation of the Covid19 virus...